Friday, December 05, 2025 | 07:20 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 3 - Corona Remedies

Zenara Pharma launches generic anti-viral pills for Covid-19 in India

Zenara Pharma, a fully-owned subsidiary of the city-based Biophore India Pharmaceuticals, on Friday announced that it has launched generic Paxlovid (Nirmatrelvir and Ritonavir) tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19. A press release from the drug maker said Zenara Pharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market this product last month. The product, which will be sold under the brand name 'Paxzen,' is being manufactured at Zenara's US FDA and EU approved state-of-the-art facility in Hyderabad, it said. Pfizer's Paxlovid has been approved by US FDA for COVID treatment. The product will be sold at a Maximum Retail Price of Rs 5,200 per box, equivalent to one full course of treatment per patient, and contains 20 tablets of Nirmatrelvir 150ml and 10 Tablets of Ritonavir 100mg. Jagadeesh Babu Rangisetty, Co-founder and Managing Director at Zenara Pharma, s

Zenara Pharma launches generic anti-viral pills for Covid-19 in India
Updated On : 09 Sep 2022 | 3:54 PM IST

Covid patients show new symptoms; impact on brain post infection: Report

While the common symptoms of Covid, include headache, fever, cough, cold, throat irritation and body ache, experts have now warned of newer symptoms

Covid patients show new symptoms; impact on brain post infection: Report
Updated On : 18 Aug 2022 | 7:10 PM IST

Lack of treatment options for long Covid create hype for unproven therapies

A recent investigation published by the British Medical Journal revealed that long COVID patients are travelling abroad to seek expensive blood washing treatment

Lack of treatment options for long Covid create hype for unproven therapies
Updated On : 22 Jul 2022 | 4:16 PM IST

Centre asks states to increase testing, vaccination amid recent Covid surge

Reviews Covid-19 situation in nine states where test positivity rates have been rising

Centre asks states to increase testing, vaccination amid recent Covid surge
Updated On : 21 Jul 2022 | 1:42 AM IST

Day-1 of free boosters: Citizens queue up to get jabs ahead of festivals

States start compiling need for additional doses, Centre seeks 50 mn doses from GAVI

Day-1 of free boosters: Citizens queue up to get jabs ahead of festivals
Updated On : 16 Jul 2022 | 12:06 AM IST

Chhattisgarh health minister infected with Covid-19 for third time

Chhattisgarh Health Minister TS Singh Deo on Saturday informed he has tested positive for COVID-19. This is the third time the minister, who returned from Delhi on Friday night, has contracted the infection. "After returning from Delhi, I got my COVID-19 test done here in which I tested positive for the coronavirus. Right now I am fine and as per suggestions of doctors, I am complying with the home isolation protocols," Singh Deo tweeted. Earlier, Singh Deo had tested positive in January this year and March last year. As on Friday, Chhattisgarh has a COVID-19 caseload of 11,53,552, including 14,036 deaths, while the active tally is 643.

Chhattisgarh health minister infected with Covid-19 for third time
Updated On : 25 Jun 2022 | 9:23 PM IST

Bharat Biotech's Covaxin induces wider immune response, say experts

However, experts say that Covaxin induces a wider immune response and thus antibody production against the spike protein may be less intense

Bharat Biotech's Covaxin induces wider immune response, say experts
Updated On : 21 Jun 2022 | 10:39 PM IST

US FDA's advisory committee endorses Novavax's protein-based Covid shot

The US Food and Drug administration's (FDA) advisory committee has recommended that regulators authorise Novavax's protein-based Covid shot.

US FDA's advisory committee endorses Novavax's protein-based Covid shot
Updated On : 08 Jun 2022 | 4:01 PM IST

Daily Covid-19 figures in Delhi will fluctuate for some time: Experts

With the count of daily new coronavirus cases in Delhi fluctuating over the last few days, experts on Thursday said the city will keep witnessing such trends for fairly long

Daily Covid-19 figures in Delhi will fluctuate for some time: Experts
Updated On : 12 May 2022 | 5:22 PM IST

Delhi sees 1,422 fresh Covid-19 cases; zero fatalities a good sign

Delhi reported 1,422 fresh COVID-19 cases and zero fatality due to the viral disease on Sunday, while the positivity rate was recorded ta 5.34 per cent, according to the health department.

Delhi sees 1,422 fresh Covid-19 cases; zero fatalities a good sign
Updated On : 08 May 2022 | 10:33 PM IST

Covid vaccine not linked to spike in child hepatitis cases, says report

Social media platforms have falsely linked the Covid vaccine with the recent spike in unexplained hepatitis in children across several countries, including the UK, the US and many others.

Covid vaccine not linked to spike in child hepatitis cases, says report
Updated On : 01 May 2022 | 3:31 PM IST

Countries with less Covid restrictions had better mental health outcomes

Countries that attempted to control transmission with stricter restrictions had worse mental health outcomes than those which did not, according The Lancet Public Health journal.

Countries with less Covid restrictions had better mental health outcomes
Updated On : 27 Apr 2022 | 4:41 PM IST

Covid incidence rises in Spain after ending mandatory use of face masks

Covid-19 infections in Spain have risen sharply following the elimination of the mandatory wearing of face masks indoors, data published by the Ministry of Health showed.

Covid incidence rises in Spain after ending mandatory use of face masks
Updated On : 27 Apr 2022 | 8:48 AM IST

Millions of Covid-19 shots in US set to go waste as vaccine rollout slowers

Millions of unused Covid-19 doses in the United States are set to go wasted as the country's vaccination rates continued to decline amid an uptick of new infections.

Millions of Covid-19 shots in US set to go waste as vaccine rollout slowers
Updated On : 27 Apr 2022 | 7:21 AM IST

Over 1.92 bn Covid-19 vaccine doses provided to States, UTs: Centre

More than 1.92 billion vaccine doses have been provided to States and Union Territories till date, informed the Ministry of Health and Family Welfare

Over 1.92 bn Covid-19 vaccine doses provided to States, UTs: Centre
Updated On : 25 Apr 2022 | 1:05 PM IST

Over 201.6 mn unutilised COVID-19 vaccine doses available, says Centre

More than 201.6 mn unutilised COVID-19 vaccine doses are still available with States and Union Territories (UTs) to be administered, informed the Ministry of Health and Family Welfare on Thursday

Over 201.6 mn unutilised COVID-19 vaccine doses available, says Centre
Updated On : 21 Apr 2022 | 11:08 AM IST

Scientists developing chewing gum that could cut Covid transmission

Scientists are developing a chewing gum laced with a plant-grown protein that serves as a "trap" for the SARS-CoV-2 virus, which causes COVID-19, reducing viral load in saliva

Scientists developing chewing gum that could cut Covid transmission
Updated On : 06 Dec 2021 | 5:22 PM IST

Antidepressant fluvoxamine may reduce risk of Covid-19 hospitalisation

Researchers treated 739 randomly selected Brazilian COVID-19 patients with fluvoxamine, with another 733 receiving a placebo, between January 15 to August 6 of this year.

Antidepressant fluvoxamine may reduce risk of Covid-19 hospitalisation
Updated On : 28 Oct 2021 | 12:38 PM IST

16,156 new Covid-19 infections in India; active cases lowest in 243 days

With 16,156 people testing positive for coronavirus infection in a day, India's total tally of Covid-19 cases rose to 3,42,31,809

16,156 new Covid-19 infections in India; active cases lowest in 243 days
Updated On : 28 Oct 2021 | 10:28 AM IST

Synthetic SARS-CoV-2 could be used as antiviral therapy for Covid-19: Study

Researchers have designed a synthetic defective SARS-CoV-2 that can interfere with growth of real virus, potentially leading to the extinction of both Covid-19 causing pathogen and the artificial one

Synthetic SARS-CoV-2 could be used as antiviral therapy for Covid-19: Study
Updated On : 13 Jul 2021 | 12:41 PM IST